Business Context and Reporting Period
This Form 8-K Current Report from HealthStream, Inc. (HSTM) covers events occurring on May 4, 2026, with the report filed on May 8, 2026. The filing primarily addresses executive leadership changes and associated compensatory arrangements.
Key Financial Metrics
The filing does not provide specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. It references a press release issued on May 4, 2026, regarding results of operations for the three months ended March 31, 2026, but does not include those figures within this document.
Material Changes
The material change reported is the promotion of Michael M. Collier to Chief Operating Officer and Executive Vice President, effective May 4, 2026. He previously served as EVP, Corporate Strategy, Development & Operations.
Guidance, Outlook, and Management Commentary
Executive Roles and Strategy: Mr. Collier will lead enterprise operations, including customer experience, corporate development, M&A, legal, HR, and partnerships. He will also serve as the executive sponsor for the Company's AI transformation, focusing on AI readiness and internal process support.
Compensatory Arrangements:
- Michael M. Collier: Granted stock options for 18,781 shares at an exercise price of $23.96 per share. Vesting is time-based over five years (15%, 20%, 20%, 20%, 25%). He also received an increase in annual base salary, eligibility for the annual cash bonus plan at the EVP level, and eligibility for annual RSU awards.
- Robert A. Frist, Jr. (CEO): Granted stock options for 18,781 shares at an exercise price of $23.96 per share. Vesting terms match Mr. Collier's (15%, 20%, 20%, 20%, 25% over five years).
Risks and Contingencies: The filing states there are no undisclosed arrangements regarding Mr. Collier's selection and no family relationships with other directors or officers. No specific financial risks or contingencies are detailed in this report.
Investor Verification Checklist
- Verify the specific financial results for the quarter ended March 31, 2026, in the referenced May 4, 2026 press release.
- Confirm the total number of shares available under the 2022 Omnibus Incentive Plan post-grant.
- Review the Company's Annual Report on Form 10-K for the year ended December 31, 2025, for Mr. Collier's full business background.
- Monitor future filings for details on the AI transformation strategy and its impact on operational costs or revenue.